Stay updated on Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.

Latest updates to the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page
- CheckyesterdayChange DetectedNew help/navigation items were added to the study details page: How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment label formatting was adjusted and the revision tag in the footer updated to v3.6.0.SummaryDifference0.5%

- Check8 days agoChange DetectedRevision metadata on the page was updated from v3.5.4 to v3.5.5, indicating a minor update to the page versioning without altering the study information.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedFooter revision updated from v3.5.3 to v3.5.4, signaling a standard site version update. No visible changes to the study details or page functionality were observed.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s revision/build identifier was updated from v3.5.2 to v3.5.3, reflecting a minor website release without changing the displayed study record.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.